investments

CEOs

Steve Orndorff, Accera

Steve Orndorff, Accera "Inventages provided critical funding to enable a Phase II clinical trial that met the highest standards of the FDA. Now, with their expertise and network of experts they are assisting us in maximizing shareholder value by exploiting the various ways to develop pharmaceutical and nutritional products worldwide."

Back
Steve Orndorff, Accera
Steve Orndorff, Accera:
"Inventages provided critical funding to enable a Phase II clinical trial that met the highest standards of the FDA." More...